Somaxon Pharmaceuticals Appoints Tran Nguyen as CFO
Somaxon Pharmaceuticals, a specialty pharmaceutical company, has appointed Tran Nguyen as vice president and chief financial officer (CFO).
Nguyen brings to Somaxon over 10 years of finance experience primarily focused in the life science industry. He was most recently chief financial officer (CFO) of Metabasis Therapeutics, a biopharmaceutical company that was acquired by Ligand Pharmaceuticals in January 2010. Prior to Metabasis, Nguyen was a vice president in the healthcare investment banking groups at Citi Global Markets and Lehman Brothers, where he successfully executed numerous capital raising and strategic transactions for life science clients.